Gifts in Memory Of
Forever Funds
A gift in honour of your loved one could continuously help families with a seriously ill child in desperate need for support, building a never-ending legacy.
How you can leave a legacy for your loved one.
Giving in memory of a loved one
We know that your child with NKH must be so very loved – we‘ are very grateful that you are considering honouring your loved one through a legacy gift at this very difficult time.
What is a forever fund? Typically, all the donations and gifts we receive are used for NKH Research, and to support children and families living with NKH. However, some families have donated funds to build a legacy for their loved one. These funds are not spent and are instead invested in perpetuity (forever).
The income generated from the forever fund is used support the Mikaere Foundation mission: to give children with NKH a future. It allows continuous, never ending income, in your loved ones honour. A legacy of giving, so we can change the face of NKH across generations, whatever may come.
Forever Fund questions
Why we need you
The Mikaere Foundation needs your support more than ever. By fundraising, you’ll help fund:
- Groundbreaking research into effective treatment and gene therapy therapy for Nonketotic Hyperglycinemia (NKH) – drastically changing the outcome for children born with NKH.
- Support services for children and families living with NKH. With NKH comes seizures, dystonia, pain and developmental delay.
- Outreach to newly diagnosed families, so they have support in their corner, right when they need it.
- Getting NKH specific information to families, nurses, therapists, carers and doctors.

£50
could fund special restriction enzymes, used in NKH Research. These work like molecular scissors to cut up the long strands of DNA in our cells. This is vital in helping us learn more about the genetic mutations of NKH.
£100
could fund a months worth of outreach, providing NKH information to newly diagnosed families right when they need it most.
£1250
could fund a week of a post doc researcher, analysing sample assays, which tell us if NKH gene therapy is working in our models, getting us closer to a cure.